2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Diagnostics And Therapeutics
Cancer diagnostics and therapeutics represent critical fronts in cancer research, aiming to improve detection and treatment outcomes. Diagnostic advancements, ranging from imaging techniques to liquid biopsies, enable earlier detection, leading to more effective intervention strategies. Molecular profiling and genetic testing further personalize treatment approaches, allowing clinicians to target specific mutations driving cancer growth. Therapeutic innovations include targeted therapies, immunotherapies, and precision medicine, which exploit tumor vulnerabilities while minimizing adverse effects on healthy tissues. Emerging modalities like CAR-T cell therapy hold promise for combating hematologic malignancies. Additionally, advancements in nanotechnology offer new avenues for drug delivery, enhancing treatment efficacy and reducing systemic toxicity. As research continues to unravel the complexities of cancer biology, the synergy between diagnostics and therapeutics stands poised to revolutionize cancer care, offering hope for improved outcomes and enhanced quality of life for patients.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China